Impact of Patient Selection on Performance of an Early Rule-Out Pathway for Myocardial Infarction: From Research to the Real World

Circulation. 2023 Jan 31;147(5):447-449. doi: 10.1161/CIRCULATIONAHA.122.062419. Epub 2023 Jan 30.

Authors

Anda Bularga^{1

2}, Kuan ken Lee¹, Anoop S V Shah³, Atul Anand¹, Andrew R Chapman¹, Chris Tuck¹, David E Newby¹, Sarah Jenks⁴, Nicholas L Mills^{1

2}, Dorien M Kimenai¹

Affiliations

¹ BHF Centre for Cardiovascular Science (A.B., K.K.L., A.A., A.R.C., C.T., D.E.N., N.L.M., D.M.K.), University of Edinburgh, United Kingdom.
² Usher Institute (A.A., N.L.M.), University of Edinburgh, United Kingdom.
³ Department of Non-communicable Disease, London School of Hygiene and Tropical Medicine, United Kingdom (A.S.V.S.).
⁴ Department Clinical Biochemistry, Royal Infirmary of Edinburgh, United Kingdom (S.J.).

No abstract available

Keywords: acute coronary syndrome; myocardial infarction; troponin I.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acute Coronary Syndrome*
Biomarkers
Emergency Service, Hospital
Humans
Myocardial Infarction* / diagnosis
Myocardial Infarction* / therapy
Patient Selection
Troponin T

Substances

Biomarkers
Troponin T

Grants and funding